Kumar P - Search Results

1

[131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.

Kumar P, McQuarrie SA, Zhou A, McEwan AJ, Wiebe LI. Kumar P, et al. Nucl Med Biol. 2005 Aug;32(6):647-53. doi: 10.1016/j.nucmedbio.2005.04.019. Nucl Med Biol. 2005. PMID: 16026712

2

Synthesis and biological activity of 5-(2,2-difluorocyclopropyl)-2'-deoxyuridine deoxyuridine diastereomers.

Tandon M, Singh S, Xu L, Kumar P, Wiebe LI, Knaus EE, Gati WP, Tempest ML. Tandon M, et al. Among authors: kumar p. Drug Des Discov. 1992;9(1):79-91. Drug Des Discov. 1992. PMID: 1333829

3

Radioiodinated azomycin pyranoside (IAZP): a novel non-invasive marker for the assessment of tumor hypoxia.

Mannan RH, Mercer JR, Wiebe LI, Kumar P, Somayaji VV, Chapman JD. Mannan RH, et al. Among authors: kumar p. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):60-7. J Nucl Biol Med (1991). 1992. PMID: 1450228

4

Detection of new metabolites of trifluridine (F3TdR) using 19F NMR spectroscopy.

Tandon M, Kumar P, Wiebe G, Wiebe LI. Tandon M, et al. Among authors: kumar p. Biochem Pharmacol. 1992 Dec 1;44(11):2223-8. doi: 10.1016/0006-2952(92)90350-r. Biochem Pharmacol. 1992. PMID: 1472088

5

alpha-Trifluoromethyl-beta-alanyl glycine (F3MBAG): a novel mammalian metabolite of trifluridine (F3TdR).

Tandon M, Kumar P, Wiebe LI. Tandon M, et al. Among authors: kumar p. Biochem Pharmacol. 1994 Aug 30;48(5):1033-41. doi: 10.1016/0006-2952(94)90375-1. Biochem Pharmacol. 1994. PMID: 8093091

6

Synthesis, radiolabeling, and biodistribution of putative metabolites of iodoazomycin arabinoside.

Lee HC, Kumar P, McEwan AJ, Wiebe LI, Mercer JR. Lee HC, et al. Among authors: kumar p. Nucl Med Biol. 2000 Jan;27(1):61-8. doi: 10.1016/s0969-8051(99)00089-x. Nucl Med Biol. 2000. PMID: 10755647

7

Microwave-assisted (radio)halogenation of nitroimidazole-based hypoxia markers.

Kumar P, Wiebe LI, Asikoglu M, Tandon M, McEwan AJ. Kumar P, et al. Appl Radiat Isot. 2002 Nov;57(5):697-703. doi: 10.1016/s0969-8043(02)00185-9. Appl Radiat Isot. 2002. PMID: 12433044

8

[99mTc]Technetium labelled PnAo-azomycin glucuronides: a novel class of imaging markers of tissue hypoxia.

Kumar P, Wiebe LI, Mannan RH, Zhang Z, Xia H, McEwan AJ. Kumar P, et al. Appl Radiat Isot. 2002 Nov;57(5):719-28. doi: 10.1016/s0969-8043(02)00188-4. Appl Radiat Isot. 2002. PMID: 12433047

9

Synthesis of 1-beta-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (beta-IAZA): a novel marker of tissue hypoxia.

Kumar P, Ohkura K, Beiki D, Wiebe LI, Seki K. Kumar P, et al. Chem Pharm Bull (Tokyo). 2003 Apr;51(4):399-403. doi: 10.1248/cpb.51.399. Chem Pharm Bull (Tokyo). 2003. PMID: 12672991 Free article.

10

[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.

Sorger D, Patt M, Kumar P, Wiebe LI, Barthel H, Seese A, Dannenberg C, Tannapfel A, Kluge R, Sabri O. Sorger D, et al. Among authors: kumar p. Nucl Med Biol. 2003 Apr;30(3):317-26. doi: 10.1016/s0969-8051(02)00442-0. Nucl Med Biol. 2003. PMID: 12745023

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,797 results

Search Page

Filters